A clinical trial of autologous adipose-derived regenerative cell transplantation for a postoperative enterocutaneous fistula

Tsunekazu Mizushima, Hidekazu Takahashi, Hiroshi Takeyama, Atsushi Naito, Naotsugu Haraguchi, Mamoru Uemura, Junichi Nishimura, Taishi Hata, Ichiro Takemasa, Hirofumi Yamamoto, Yuichiro Doki, Masaki Mori

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Purpose: Adipose-derived stem cell (ADSC) transplantation is expected to be a minimally invasive, but effective, treatment for postoperative enterocutaneous fistulas associated with poor blood flow and chronic inflammation. The aim of this study was to assess the safety and efficacy of a novel ADSC therapy for this condition. Methods: We conducted an open-label, single-arm exploratory phase I study to assess the safety and efficacy of a novel ADSC therapy. Using the Celution system, we isolated adipose-derived regenerative cells (ADRCs) containing abundant ADSCs from liposuction-obtained gluteal adipose tissue. A mixture of ADRCs and fibrin glue was subsequently transplanted into the fistula, and ADRCs were percutaneously and endoscopically injected around the fistula. We evaluated the safety and feasibility of ADRC transplantation and fistula closure in six patients (UMIN000007316). Results: ADRC transplantation was completed in all patients. The fistula closure rates were 83.3 % at 4 and 12 weeks and 100 % at 24 weeks. All patients had grade 1 pain and subcutaneous hemorrhage at the liposuction sites, but no serious adverse events related to this procedure were observed. Conclusions: Transplantation of autologous ADRCs is safe, feasible and advantageous, as it can secure a sufficient cell count without culture or multiple passages, and will likely be effective for a postoperative enterocutaneous fistula.

Original languageEnglish
Pages (from-to)835-842
Number of pages8
JournalSurgery today
Volume46
Issue number7
DOIs
Publication statusPublished - Jul 1 2016
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Surgery

Fingerprint Dive into the research topics of 'A clinical trial of autologous adipose-derived regenerative cell transplantation for a postoperative enterocutaneous fistula'. Together they form a unique fingerprint.

  • Cite this

    Mizushima, T., Takahashi, H., Takeyama, H., Naito, A., Haraguchi, N., Uemura, M., Nishimura, J., Hata, T., Takemasa, I., Yamamoto, H., Doki, Y., & Mori, M. (2016). A clinical trial of autologous adipose-derived regenerative cell transplantation for a postoperative enterocutaneous fistula. Surgery today, 46(7), 835-842. https://doi.org/10.1007/s00595-015-1246-8